VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares rose 16.7% on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 143,956 shares traded hands during trading, an increase of 29% from the average daily volume of 111,732 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Price Performance
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41. The company’s 50 day moving average is C$0.13 and its 200-day moving average is C$0.17. The stock has a market cap of C$15.72 million, a PE ratio of -3.33 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- The Risks of Owning Bonds
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is Forex and How Does it Work?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
